Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Encision Inc. (ECIA : OTC)

• Company Description    Encision Inc. designs and manufactures innovative surgical devices that allow the surgeon to optimize technique and patient safety during a broad range of surgical procedures. Based in Boulder, Colorado, the Company pioneered the development of patented AEM? Laparoscopic Instruments to improve electrosurgery and reduce the chance for patient injury in minimally invasive surgery. Number of Employees: 35

• Price / Volume Information    Yesterday's Closing Price: $0.61 Daily Weekly Monthly 20 Day Moving Average: 1,441 shares Shares Outstanding: 11.72 (millions) Market Capitalization: $7.10 (millions) Beta: 0.21 52 Week High: $1.50 52 Week Low: $0.61 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -39.40% -31.75% 12 Week -44.91% -39.44% Year To Date -59.33% -44.98%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 6797 WINCHESTER CIRCLE - BOULDER,CO 80301 USA ph: 303-444-2600 fax: 303-444-2693 None http://www.encision.com

• General Corporate Information    Officers Gregory J. Trudel - President and CEO Mala Ray - Principal Accounting Officer & Principal Financial Vern D. Kornelsen - Director Patrick W. Pace - Director David W. Newton - Director Peer Information Encision Inc. (ABMD) Encision Inc. (DMDS) Encision Inc. (CPWY.) Encision Inc. (EQUR) Encision Inc. (ECIA) Encision Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 29254Q104 SIC: 3841 Fiscal Year Fiscal Year End: March Last Reported Quarter: 12/01/21 Next Expected EPS Date: 05/18/22 Share - Related Items Shares Outstanding: 11.72 Most Recent Split Date: (:1) Beta: 0.21 Market Capitalization: $7.10 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/18/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 15.15 PEG Ratio: - Price Ratios Price/Book: 2.24 Price/Cash Flow: 93.64 Price / Sales: 0.86 EPS Growth vs. Year Ago Period: -100.00% vs. Previous Quarter: -100.00% Sales Growth vs. Year Ago Period: -10.12% vs. Previous Quarter: -8.00% ROE 03/31/22 - - 12/31/21 - 15.15 09/30/21 - 37.27 ROA 03/31/22 - - 12/31/21 - 8.13 09/30/21 - 19.32 Current Ratio 03/31/22 - - 12/31/21 - 3.13 09/30/21 - 2.83 Quick Ratio 03/31/22 - - 12/31/21 - 2.03 09/30/21 - 1.82 Operating Margin 03/31/22 - - 12/31/21 - 5.51 09/30/21 - 12.66 Net Margin 03/31/22 - - 12/31/21 - 5.51 09/30/21 - 12.66 Pre-Tax Margin 03/31/22 - - 12/31/21 - 5.52 09/30/21 - 12.67 Book Value 03/31/22 - - 12/31/21 - 0.27 09/30/21 - 0.27 Inventory Turnover 03/31/22 - - 12/31/21 - 2.73 09/30/21 - 2.76 Debt-to-Equity 03/31/22 - - 12/31/21 - 0.07 09/30/21 - 0.07 Debt-to-Capital 03/31/22 - - 12/31/21 - 6.26 09/30/21 - 6.36

Powered by Zacks Investment Research ©